OCT 01, 2020 8:15 AM PDT

HPV Vaccine Protects Against Cervical Cancer, Large Study Finds

WRITTEN BY: Annie Lennon

It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and cervical pre-cancer. However, from a large-scale study, researchers have now shown that the vaccine can also prevent invasive cervical cancer, the most severe form of the disease. 

“This is the first time that we, on a population level, are able to show that HPV vaccination is protective not only against cellular changes that can be precursors to cervical cancer but also against actual invasive cervical cancer,” says Jiayao Lei, a researcher at Karolinska Institutet in Sweden and an author of the study. 

“It is something we have long suspected but that we are now able to show in a large national study linking HPV vaccination and development of cervical cancer at the individual level.”

For the study, the researchers followed close to 1.7 million women aged between 10 and 30 for 11 years. Among the women, over 500,000 were vaccinated against HPV before the age of 17. 

In the end, they found that while 19 vaccinated women were diagnosed with cervical cancer within the period, 538 unvaccinated women were also diagnosed. This equals out to 47 and 94 diagnoses per 100,000 women, thus showing that the HPV vaccine is likely protective against the condition. 

In particular, the researchers found that HPV vaccination reduced the risk of developing cervical cancer by 88% among those vaccinated before the age of 17, and by around 50% if vaccinated between the ages of 17 and 30. 

They say that the discrepancy in effectiveness may be because girls under the age of 17 are less likely to have been exposed to the HPV infection and that the HPV vaccination has no therapeutic effect against a pre-existing infection. 

As such, the researchers conclude that their study shows that HPV vaccination may significantly reduce one’s risk of developing cervical cancer. They thus recommend that HPV vaccinations continue to be given to children and adolescents via national vaccination programs. 

 

Sources: Technology NetworksNBC

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 08, 2020
Neuroscience
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
NOV 08, 2020
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
Researchers from the F.M. Kirby Neurobiology Center in the US have discovered a new approach to restore myelin sheaths, ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
DEC 04, 2020
Drug Discovery & Development
OTC Drug Found Safe for Multiple Myeloma
DEC 04, 2020
OTC Drug Found Safe for Multiple Myeloma
Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapse ...
DEC 18, 2020
Drug Discovery & Development
Antibiotic Reduces Risk of Deafness
DEC 18, 2020
Antibiotic Reduces Risk of Deafness
Gentamicin is an antibiotic recently shown to reduce the risk of developing deafness according to a Stanford Medicine st ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
Loading Comments...